Specialty Therapy

  • Multiple Sclerosis Patients

  • Transplant Patients

  • Organ Patients

  • Dialysis Patients


Specialty infusion drugs require highly specialized services and management for patients to achieve their therapeutic goals. At DeliverIT Infusion & Specialty we administer these services safely and effectively. 


We take great pride in providing seamless, personalized clinical care from hospital to home.


The ability to provide expert-led, individualized treatment plans in the home and at alternate treatment sites is what makes it possible for patients, manufacturers, and health care systems to use our services to achieve optimal outcomes while controlling costs.  


If you have any question regarding Specialty Infusion Therapy our Pharmacist are available for a free consultation. 

Multiple Sclerosis 

Natalizumab (Tysabri)

Natalizumab works by stopping the damaging immune cells from entering your brain and spinal cord. You receive this drug once every four weeks.

Mitoxantrone (Novantrone)

While it’s also a chemotherapy drug used to treat cancer, mitoxantrone is an MS infusion treatment. It may work best for people with secondary progressive MS or rapidly worsening MS. That’s because it’s an immunosuppressant, which means it works to stop your immune system’s reaction to MS attacks. This effect can lessen your symptoms of an MS flare.

Ocrelizumab (Ocrevus)

Ocrelizumab is the newest infusion treatment for MS. It was approved in 2017.

Ocrelizumab is used to treat relapsing or primary progressive forms of MS. In fact, it’s the first drug approved to treat primary progressive MS.

This medication is thought to work by targeting the B lymphocytes that are responsible for myelin sheath damage and repair.

Transplant Patients

Infusion is the actual transplant process in which the stem cells from bone marrow or blood are infused into the patient through a central (in the chest) intravenous catheter.

The infusion of stem cells is painless, although some side effects may occur, and most patients are awake, but they may have light sedation.


Typically, the process lasts from 30 minutes to 1 hour, depending on the volume of cells.

Contact our office for more details regarding the services we provide.

Orphan Drugs 

Drugs that are not developed by the pharmaceutical industry for economic reasons but which respond to public health need.

For more information please feel free to contact our office and someone will be available to assist you.

Dialysis Patients

Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients. 


For more information contact our office and someone will be happy to assist you.